RAI14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.061200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.339800E-02
Normal-vs-Stage2
8.888400E-01
Normal-vs-Stage3
8.808400E-01
Normal-vs-Stage4
9.319800E-01
Stage1-vs-Stage2
3.781600E-02
Stage1-vs-Stage3
5.500200E-01
Stage1-vs-Stage4
3.891600E-01
Stage2-vs-Stage3
9.688200E-01
Stage2-vs-Stage4
7.892200E-01
Stage3-vs-Stage4
8.384600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.766200E-01
Normal-vs-AfricanAmerican
5.878800E-01
Normal-vs-Asian
8.952000E-01
Caucasian-vs-AfricanAmerican
8.482000E-01
Caucasian-vs-Asian
7.883600E-01
AfricanAmerican-vs-Asian
7.297600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.406000E-01
Normal-vs-Female
9.948000E-01
Male-vs-Female
1.055020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.291800E-01
Normal-vs-Age(41-60Yrs)
7.734400E-01
Normal-vs-Age(61-80Yrs)
6.083000E-01
Normal-vs-Age(81-100Yrs)
3.927000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.731600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.159000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.688200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.362600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.715600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.971600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.202400E-01
Normal-vs-Daily Drinker
1.967210E-01
Normal-vs-Weekly Drinker
7.219200E-01
Normal-vs-Occasional Drinker
8.318600E-01
Normal-vs-Social Drinker
4.090400E-01
Non Drinker-vs-Daily Drinker
8.754600E-01
Non Drinker-vs-Weekly Drinker
9.639800E-02
Non Drinker-vs-Occasional Drinker
2.109200E-01
Non Drinker-vs-Social Drinker
9.108400E-02
Daily Drinker-vs-Weekly Drinker
8.792000E-02
Daily Drinker-vs-Occasional Drinker
1.878790E-01
Daily Drinker-vs-Social Drinker
8.337600E-02
Weekly Drinker-vs-Occasional Drinker
3.468600E-01
Weekly Drinker-vs-Social Drinker
9.157800E-01
Occasional Drinker-vs-Social Drinker
3.101400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.230400E-01
Normal-vs-Grade 2
6.749800E-01
Normal-vs-Grade 3
6.901200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.272200E-02
Grade 1-vs-Grade 3
5.896000E-02
Grade 1-vs-Grade 4
6.230400E-01
Grade 2-vs-Grade 3
5.886200E-01
Grade 2-vs-Grade 4
6.749800E-01
Grade 3-vs-Grade 4
6.901200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.914000E-01
Normal-vs-NonDiabetic
7.940800E-01
Diabetic-vs-NonDiabetic
9.022400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.069600E-01
Normal-vs-NoPancreatitis
7.737800E-01
Pancreatitis-vs-NoPancreatitis
4.053800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.202600E-01
Normal-vs-N1
8.123000E-01
N0-vs-N1
8.427600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.743400E-01
Normal-vs-TP53-NonMutant
7.823800E-02
TP53-Mutant-vs-TP53-NonMutant
2.661600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
